All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit Know ALL.

  TRANSLATE

The ALL Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the ALL Hub cannot guarantee the accuracy of translated content. The ALL Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The ALL Hub
Brought to you by Scientific Education Support

The ALL Hub is an independent medical education platform, sponsored by Amgen and Autolus. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

View all

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

CAR-T 2023

Share:

Feb 9, 2023

X post image

24 Feb 2023

Stay up to date!

Review our live coverage of the CAR T-cell Meeting over the weekend.

Including key insights from André Baruchel, Roman Hájek, Candice Hendricks and many more!

#CART23 #leusm

View on 

X post image

11 Feb 2023

CONGRESS | #CART23
Gaurav Narula presents access to CAR-T on a global scale – India. Many treatment challenges exist in this region including patient volume, financial burden, malnutrition and patient tracking. Key clinical trials are ongoing. #leusm #medicalcongress

View on 

X post image

11 Feb 2023

CONGRESS | #CART23
Kevin Hay @bccancerfdn presents access to CAR-T on a global scale – Canada. While Canada represents global leader in CAR-T cell therapy, access is to treatment is still limited in some areas due to geographical distribution and landscape challenges. #leusm

View on 

X post image

11 Feb 2023

CONGRESS | #CART23
Candice Hendricks, @UPTuks presents access to CAR-T on a global scale – South Africa. Currently, there is no patient access to CAR-T products for patients in SA. However progress is being made, with early clinical trials expected to start in 2023. #leusm

View on 

X post image

11 Feb 2023

CONGRESS | #CART23
Roman Hajek presents access to CAR-T on a global scale - Central and Eastern Europe. Discrepancies exist in the availability and reimbursement of CAR-T product cost across the region. Access to clinical trials represents a key challenge for patients. #leusm

View on 

X post image

11 Feb 2023

CONGRESS | #CART23
@i_yakoub_agha presents updates to European guidelines on CAR T-cell therapy toxicity management, including EBMT/EHA recommendations.
#leusm #medicalcongress #hematology

View on 

X post image

9 Feb 2023

CONGRESS | #CART23 @MaxMamonkin, @CAGTHouston discusses CD5 and CD7 targeted CAR T-cell therapy for T-ALL and TCL, highlighting data from the MAGNETA and CRIMSON-NE trials. Both targets can offer advantages, although challenges remain. #leusm #medicalcongress #hematology

View on 

X post image

9 Feb 2023

CONGRESS | #CART23 Andre Baruchel, @HopRobertDebre speaks on CAR-T cell therapy for #ALL. Real-world data shows improved outcomes with CAR-T treatment. Factors such as dose, tumor burden and persistence are key drivers of outcome. CRS and neurotoxicity remain challenges. #leusm

View on 

<span>&nbsp;</span>

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content

More about...

CAR-T 2023EHA–EBMT European CAR T-Cell Meeting

Newsletter

Subscribe to get the best content delivered to your inbox